SCHEMBL19851934

SCHEMBL19851934

[N-]=[N+]=NCCCCC1CCN(C(=O)I)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 2/20 0.34
▸ ITGA2B P08514 2/20 0.34
▸ IDUA P35475 1/20 0.33
▸ HDAC3 O15379 3/20 0.32
▸ HDAC4 P56524 3/20 0.32
▸ HDAC1 Q13547 3/20 0.32
▸ HDAC7 Q8WUI4 3/20 0.32
▸ HDAC2 Q92769 3/20 0.32
▸ HDAC10 Q969S8 3/20 0.32
▸ HDAC11 Q96DB2 3/20 0.32
▸ HDAC8 Q9BY41 3/20 0.32
▸ HDAC6 Q9UBN7 3/20 0.32
▸ HDAC9 Q9UKV0 3/20 0.32
▸ HDAC5 Q9UQL6 3/20 0.32
▸ GNAI3 P08754 2/20 0.31
▸ GNAO1 P09471 2/20 0.31
▸ GNAI1 P63096 2/20 0.31
▸ PKM P14618 1/20 0.31
▸ DPP7 Q9UHL4 2/20 0.31
▸ DPP8 Q6V1X1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21103101 0.88 EPHX2 (0.35) ITGB3ITGA2BIDUAGNAI3GNAO1
SCHEMBL25231961 0.81 ITGB3 (0.38) ITGB3ITGA2BIDUAHDAC3HDAC4
SCHEMBL19834771 0.77 HDAC3 (0.59) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22223259 0.74 GNAI3 (0.48) ITGB3ITGA2BGNAI3GNAO1GNAI1
SCHEMBL30407016 0.74 GPR119 (0.49) PKM
SCHEMBL19834786 0.73 ALDH1A1 (0.54) PKMHTTKMT2A
SCHEMBL19834819 0.73 GAA (0.49) HTT
SCHEMBL13531821 0.73 FAAH (0.49) —
SCHEMBL19834875 0.72 CYP2C9 (0.47) MEN1HTTKMT2A
SCHEMBL25277190 0.72 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018024907-A1 PIPERIDINE DERIVATIVES FOR USE IN THE TREATMENT OF PANCREATIC CANCER CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS CHUV (CH) 2018-02-08 — — WO disclosed
Send feedback